Karlinska Institute Review: Tumorigenicity and genetic stability

Company Logo
Karlinska Institute
Stockhom
Sweden
http://ki.se

Tumorigenicity and genetic stability

 
Overall: 3 stars

Date: September 25, 2014

Proposal Quality:
 
3
Ease of Contracting Process:
 
2
Comprehensive Solution:
 
2
Experience With Study Type:
 
4
Therapeutic Area Expertise:
 
4
Project Management:
 
2
Responsiveness:
 
3
Problem Solving:
 
2
Adherence to Timelines:
 
1
Adherence to Proposed Budget:
 
2
Reporting Quality / Data Accuracy:
 
2
Value (Price vs Quality):
 
1
Strength as a Partner:
 
2
Willingness to Recommend CRO:
 
1.5
 

Service Description

KI was contracted to perform tumorigenicity tests in mice of our active substance, based on human umbilical cord-derived mesenchimal stem cells. Furthermore, KI was contracted to study the genetic stability of the same cells by means of kariotype analyses.

What Went Well

The positive elements of the service are mainly the quality of the work done, as well as the quality of the people and facilities involved.

What Could Be Improved

The main improvable aspect was the communication as well as the overall price paid, which was high.

Lessons Learned from the Experience

We have learned that paying a high price not always is accompanied by a high standard, not in the quality of the technical services, but more in the quality of other factors like communication and cost/benefit ratio.